UCP1 and breast carcinoma: To examine whether our treatment might provide systematic therapeutic effect in suppressing breast cancer growth, we next used MMTV-PyMT female mice, implanting Ucp1-CRISPRa or dCas9–VP64 adipose organoids near the third nipples of 4-week-old mice (Fig. 4f).